Markus Scholz, Endowed Professor for Corporate Governance & Business Ethics, took part in a virtual roundtable discussion on the question of social responsibility of the pharmaceutical industry in times of Covid-19 at the invitation of Mag. (FH) Dieter Aigner, Managing Director Raiffeisen KAG.
Covid-19 keeps the world firmly in its grip and puts societies and values to a hard test. The insights and lessons that can be learned from this pandemic are manifold and affect almost all areas of life. It has also shown one thing: Sustainable structures are of existential importance, especially in the health sector. This applies to production sites and supply chains for medicines, medical supplies and protective clothing. It concerns the globally fair distribution of these goods, which also involves politically curbing any “best bidders” and thus also giving developing countries access to the coveted products. And it concerns the crisis organisation itself: how quickly will data be published and made transparent? How quickly can crisis concepts be implemented? How sustainable is solidarity when one’s own health is at stake, but also the health of others?
The social responsibility of the pharmaceutical industry in the times of Covid-19 was discussed under the moderation of Mag. (FH) Dieter Aigner, Managing Director Raiffeisen KAG
- Dr. Christian W. Mandl, virologist and vaccine expert; 20 years as university professor for virology at MedUni Vienna, then head of research at Novartis Vaccines in Boston, currently working in various functions in the biotech sector
- Connie Gaisbauer, Equity Analyst (Health Care), Raiffeisen KAG/Raiffeisen Bank International AG
- Dr. Markus Scholz, Endowed Professor for Corporate Governance & Business Ethics at the Vienna University of Applied Sciences of the Vienna Chamber of Commerce, Head of the Institute for Business Ethics and Sustainable Strategy (IBES)
- Erich Tauber, CEO and co-founder of Themis Bioscience GmbH
For a summary of the discussion here: https://www.investment-zukunft.at/kooperation-ist-gut-konkurrenz-fast-noch-wichtiger/
A blog entry here: https://blog.raiffeisenfonds.at/veraenderungen-der-nachhaltigkeit-durch-covid-19/